semaglutide label Doctors Petition FDA for Labeling Changes on Wegovy related medical problems GLP-1 Weight Loss Options |

They should also be aware of gallstone symptoms such as upper abdominal pain, nausea, and vomiting

As more and more treatment options with GLP-1 agonists become available, the demand will continue to increase (Table 1)

Retrospective Study #1 The first retrospective study analyzed the medical records of 283 adult patients who were taking GLP-1 medications and had also visited the dermatology department for hair loss between 2021 and 2023

As public interest in investigational medical products continues to increase, developers may be under greater pressure to make such products available to patients and their health care providers

Osteopontin (OPN) is a highly phosphorylated glycoprotein that exerts multiple functions outside of its role in bone mineralization via regulation of osteoclast function